NTHI
NeOnc Technologies Holdings, Inc.
Price Chart
Latest Quote
$5.11
| Previous Close | $5.27 |
| Open | $5.19 |
| Day High | $5.32 |
| Day Low | $4.94 |
| Volume | 159,293 |
Stock Information
| Shares Outstanding | 25.93M |
| Total Debt | $346K |
| Cash Equivalents | $139K |
| Net Income | $-38.64M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $126.55M |
| EPS (TTM) | $-1.80 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $129.57M |
| Income | $-38.64M |
| Book/sh | $-0.55 |
| Cash/sh | $0.01 |
| Employees | 5 |
Financial Ratios
| Quick Ratio | 0.02 |
| Current Ratio | 0.13 |
Returns & Margins
| ROA | -354.61% |
Ownership
| Insider Ownership | 56.68% |
| Institutional Ownership | 11.25% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -6.48 |
| P/B | -8.91 |
Analyst Data
| Recommendation | none |
| Target Price | $16.00 |
Technical Indicators
| SMA20 | $4.72 |
| SMA50 | $4.96 |
| SMA200 | $8.13 |
| RSI | 54.56 |
| ATR | 0.5694 |
| Shares Float | 7.99M |
| Short Float | 2.29% |
| Short Ratio | 2.70 |
| Rel Volume | 0.69 |
Performance History
| Week | +8.20% |
| Month | -8.96% |
| Quarter | -38.07% |
| 6 Months | -30.48% |
| YTD | -45.05% |
| Year | +14.69% |
| 10 Years | -59.70% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $4.88 | 77,096 |
| 2026-06-22 | $5.11 | 159,900 |
| 2026-06-18 | $5.27 | 373,800 |
| 2026-06-17 | $4.81 | 105,700 |
| 2026-06-16 | $5.18 | 223,200 |
| 2026-06-15 | $4.51 | 89,600 |
| 2026-06-12 | $4.75 | 641,000 |
| 2026-06-11 | $4.50 | 26,400 |
| 2026-06-10 | $4.55 | 42,300 |
| 2026-06-09 | $4.42 | 27,300 |
| 2026-06-08 | $4.49 | 66,600 |
| 2026-06-05 | $4.42 | 52,200 |
| 2026-06-04 | $4.57 | 35,400 |
| 2026-06-03 | $4.35 | 49,300 |
| 2026-06-02 | $4.58 | 69,900 |
| 2026-06-01 | $4.54 | 31,600 |
| 2026-05-29 | $4.64 | 27,900 |
| 2026-05-28 | $4.79 | 54,500 |
| 2026-05-27 | $4.84 | 66,300 |
| 2026-05-26 | $5.14 | 12,300 |
About NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.
đ° Latest News
NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone
Stocktwits âĸ 2026-06-23T14:56:44ZNeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development
Stocktwits âĸ 2026-06-16T14:03:38ZNeOnc Technologies (NTHI) Could Be Targeting A Challenging Market With A Different Strategy
Insider Monkey âĸ 2026-05-31T14:38:12ZForget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6
24/7 Wall St. âĸ 2026-05-14T15:39:27ZInsider Buys Additional US$185k In NeOnc Technologies Holdings Stock
Simply Wall St. âĸ 2025-12-02T13:03:01ZWith 61% ownership, NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) insiders have a lot riding on the company's future
Simply Wall St. âĸ 2025-11-14T11:17:36ZAI and biotech take on brain cancer
Yahoo Finance Video âĸ 2025-07-30T10:00:43ZNeOnc Technologies Holdings Insiders Lose Out As Stock Sinks To US$3.72
Simply Wall St. âĸ 2025-06-26T12:09:44ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $39,990 | $83,000 | $70,462 | $20,000 |
| Operating Revenue | $39,990 | $83,000 | $70,462 | $20,000 |
| Expenses | ||||
| Interest Expense | $2,504,567 | $2,557,055 | $2,723,396 | $200,153 |
| Total Expenses | $58,209,188 | $7,225,522 | $8,168,131 | $2,857,604 |
| Other Income Expense | $-689,543 | $-2,069,923 | $-4,100,000 | $-9,000 |
| Net Non Operating Interest Income Expense | $-3,287,469 | $-2,686,019 | $-2,723,396 | $-200,153 |
| Total Other Finance Cost | $1,110,484 | $145,097 | - | - |
| Interest Expense Non Operating | $2,504,567 | $2,557,055 | $2,723,396 | $200,153 |
| Operating Expense | $58,209,188 | $7,225,522 | $8,168,131 | $2,857,604 |
| Other Operating Expenses | $11,716,559 | $500,000 | $3,237,773 | - |
| General And Administrative Expense | $42,854,372 | $3,680,283 | $3,396,244 | $1,694,274 |
| Other Non Operating Income Expenses | - | - | - | $-9,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-62,146,210 | $-11,898,464 | $-14,921,065 | $-3,046,757 |
| Net Interest Income | $-3,287,469 | $-2,686,019 | $-2,723,396 | $-200,153 |
| Interest Income | $327,582 | $16,133 | $0 | - |
| Normalized Income | $-61,456,667 | $-9,828,541 | $-10,821,065 | $-3,046,757 |
| Net Income From Continuing And Discontinued Operation | $-62,146,210 | $-11,898,464 | $-14,921,065 | $-3,046,757 |
| Total Operating Income As Reported | $-58,240,445 | $-7,142,522 | $-12,197,669 | $-2,837,604 |
| Net Income Common Stockholders | $-62,146,210 | $-11,898,464 | $-14,921,065 | $-3,046,757 |
| Net Income | $-62,146,210 | $-11,898,464 | $-14,921,065 | $-3,046,757 |
| Net Income Including Noncontrolling Interests | $-62,146,210 | $-11,898,464 | $-14,921,065 | $-3,046,757 |
| Net Income Continuous Operations | $-62,146,210 | $-11,898,464 | $-14,921,065 | $-3,046,757 |
| Pretax Income | $-62,146,210 | $-11,898,464 | $-14,921,065 | $-3,046,757 |
| Special Income Charges | $0 | $-2,069,923 | $-4,100,000 | $0 |
| Interest Income Non Operating | $327,582 | $16,133 | $0 | - |
| Operating Income | $-58,169,198 | $-7,142,522 | $-8,097,669 | $-2,837,604 |
| Per Share | ||||
| Diluted EPS | $-3.20 | $-0.63 | $-0.80 | $-0.16 |
| Basic EPS | $-3.20 | $-0.63 | $-0.80 | $-0.16 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-58,915,639 | $-7,025,541 | $-8,097,669 | $-2,846,604 |
| Total Unusual Items | $-689,543 | $-2,069,923 | $-4,100,000 | $0 |
| Total Unusual Items Excluding Goodwill | $-689,543 | $-2,069,923 | $-4,100,000 | $0 |
| Reconciled Depreciation | $36,461 | $245,945 | $0 | - |
| EBITDA (Bullshit earnings) | $-59,605,182 | $-9,095,464 | $-12,197,669 | $-2,846,604 |
| EBIT | $-59,641,643 | $-9,341,409 | $-12,197,669 | $-2,846,604 |
| Diluted Average Shares | $19,398,776 | $18,745,865 | $18,745,865 | $18,745,865 |
| Basic Average Shares | $19,398,776 | $18,745,865 | $18,745,865 | $18,745,865 |
| Diluted NI Availto Com Stockholders | $-62,146,210 | $-11,898,464 | $-14,921,065 | $-3,046,757 |
| Gain On Sale Of Security | $-689,543 | - | - | - |
| Research And Development | $3,638,257 | $3,045,239 | $1,534,114 | $1,163,330 |
| Selling General And Administration | $42,854,372 | $3,680,283 | $3,396,244 | $1,694,274 |
| Other Gand A | $7,299,313 | $3,680,283 | $3,396,244 | $1,694,274 |
| Salaries And Wages | $35,555,059 | $0 | - | - |
| Other Special Charges | - | $2,069,923 | $4,100,000 | - |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-18,007,729 | $-5,504,961 | $-13,988,253 | $-1,575,411 |
| Total Assets | $2,823,634 | $3,417,241 | $1,265,376 | $728,682 |
| Total Non Current Assets | $1,434,923 | $1,222,038 | $0 | $0 |
| Other Non Current Assets | $47,177 | - | - | - |
| Financial Assets | $526,701 | $1,198,512 | - | - |
| Goodwill And Other Intangible Assets | $500,000 | $0 | - | - |
| Current Assets | $1,388,711 | $2,195,203 | $1,265,376 | $728,682 |
| Hedging Assets Current | $671,804 | $671,804 | $0 | - |
| Current Deferred Assets | $75,082 | $1,071,947 | $970,582 | $0 |
| Prepaid Assets | $583,096 | $386,559 | $262,932 | $95,384 |
| Cash Cash Equivalents And Short Term Investments | $58,729 | $64,893 | $31,862 | $633,298 |
| Cash And Cash Equivalents | $58,729 | $64,893 | $31,862 | $633,298 |
| Cash Financial | $58,729 | $64,893 | $31,862 | $633,298 |
| Debt | ||||
| Net Debt | $5,893,337 | - | $6,573,595 | - |
| Total Debt | $6,313,879 | $24,722 | $6,605,457 | $50,000 |
| Long Term Debt And Capital Lease Obligation | $290,682 | $0 | - | - |
| Current Debt And Capital Lease Obligation | $6,023,197 | $24,722 | $6,605,457 | $50,000 |
| Current Debt | $5,952,066 | - | $6,605,457 | $50,000 |
| Other Current Borrowings | $5,952,066 | - | $6,555,457 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $20,331,363 | $8,922,202 | $15,253,629 | $2,304,093 |
| Total Non Current Liabilities Net Minority Interest | $290,682 | $0 | $0 | $0 |
| Current Liabilities | $20,040,681 | $8,922,202 | $15,253,629 | $2,304,093 |
| Payables And Accrued Expenses | $13,762,385 | $8,162,606 | $7,556,929 | $1,341,593 |
| Payables | $12,005,244 | $8,162,606 | $7,556,929 | $1,341,593 |
| Other Payable | $4,892,059 | $4,641,250 | $4,600,000 | - |
| Accounts Payable | $7,113,185 | $3,521,356 | $2,956,929 | $1,341,593 |
| Current Notes Payable | - | $0 | $50,000 | $50,000 |
| Current Deferred Liabilities | - | - | $0 | $500,000 |
| Equity | ||||
| Common Stock Equity | $-17,507,729 | $-5,504,961 | $-13,988,253 | $-1,575,411 |
| Total Equity Gross Minority Interest | $-17,507,729 | $-5,504,961 | $-13,988,253 | $-1,575,411 |
| Stockholders Equity | $-17,507,729 | $-5,504,961 | $-13,988,253 | $-1,575,411 |
| Retained Earnings | $-112,754,655 | $-50,608,445 | $-38,709,981 | $-23,788,916 |
| Preferred Stock Equity | - | - | - | $3,030 |
| Other | ||||
| Treasury Shares Number | $302,766 | - | - | - |
| Ordinary Shares Number | $21,687,922 | $18,745,865 | $18,745,865 | $18,745,865 |
| Share Issued | $21,990,688 | $18,745,865 | $18,745,865 | $18,745,865 |
| Tangible Book Value | $-18,007,729 | $-5,504,961 | $-13,988,253 | $-1,575,411 |
| Invested Capital | $-11,555,663 | $-5,504,961 | $-7,382,796 | $-1,525,411 |
| Working Capital | $-18,651,970 | $-6,726,999 | $-13,988,253 | $-1,575,411 |
| Capital Lease Obligations | $361,813 | $24,722 | $0 | - |
| Total Capitalization | $-17,507,729 | $-5,504,961 | $-13,988,253 | $-1,575,411 |
| Treasury Stock | $2,706,307 | $0 | - | - |
| Additional Paid In Capital | $97,951,035 | $45,101,675 | $24,720,072 | $22,212,455 |
| Capital Stock | $2,198 | $1,809 | $1,656 | $1,050 |
| Common Stock | $2,198 | $1,809 | $1,656 | $1,050 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $290,682 | $0 | - | - |
| Current Capital Lease Obligation | $71,131 | $24,722 | $0 | - |
| Pensionand Other Post Retirement Benefit Plans Current | $255,099 | $734,874 | $1,091,243 | $412,500 |
| Current Accrued Expenses | $1,757,141 | $0 | - | - |
| Net PPE | $361,045 | $23,526 | $0 | - |
| Gross PPE | $361,045 | $23,526 | $0 | - |
| Other Properties | $361,045 | $23,526 | - | - |
| Current Deferred Revenue | - | - | $0 | $500,000 |
| Dueto Related Parties Current | - | - | - | $0 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-20,863,948 | $-4,213,916 | $-1,880,012 | $-881,736 |
| Operating Activities | ||||
| Operating Cash Flow | $-20,363,948 | $-4,213,916 | $-1,880,012 | $-881,736 |
| Cash Flow From Continuing Operating Activities | $-20,363,949 | $-4,213,916 | $-1,880,012 | $-881,736 |
| Operating Gains Losses | $689,543 | $2,069,923 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-500,000 | - | - | - |
| Investing Cash Flow | $-500,000 | $0 | - | - |
| Cash Flow From Continuing Investing Activities | $-500,000 | $0 | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $17,157,784 | $4,615,789 | $450 | $2,400,000 |
| Financing Cash Flow | $20,857,784 | $4,246,947 | $1,278,576 | $1,490,000 |
| Cash Flow From Continuing Financing Activities | $20,857,784 | $4,246,947 | $1,278,576 | $1,490,000 |
| Net Common Stock Issuance | $17,157,784 | $4,615,789 | $450 | $2,400,000 |
| Common Stock Issuance | $17,157,784 | $4,615,789 | $450 | $2,400,000 |
| Net Other Financing Charges | - | $-469,793 | $-94,569 | $-700,000 |
| Other | ||||
| Repayment Of Debt | $-600,000 | $-791,077 | $-2,135,277 | $-335,000 |
| Issuance Of Debt | $4,300,000 | $892,028 | $3,507,972 | $125,000 |
| End Cash Position | $58,729 | $64,893 | $31,862 | $633,298 |
| Beginning Cash Position | $64,893 | $31,862 | $633,298 | $25,034 |
| Changes In Cash | $-6,164 | $33,031 | $-601,436 | $608,264 |
| Net Issuance Payments Of Debt | $3,700,000 | $100,951 | $1,372,695 | $-210,000 |
| Net Short Term Debt Issuance | $-300,000 | $100,951 | $1,372,695 | $-210,000 |
| Short Term Debt Payments | $-600,000 | $-791,077 | $-2,135,277 | $-335,000 |
| Short Term Debt Issuance | $300,000 | $892,028 | $3,507,972 | $125,000 |
| Net Long Term Debt Issuance | $4,000,000 | $0 | - | - |
| Long Term Debt Issuance | $4,000,000 | $0 | - | - |
| Net Intangibles Purchase And Sale | $-500,000 | $0 | - | - |
| Purchase Of Intangibles | $-500,000 | $0 | - | - |
| Change In Working Capital | $2,138,648 | $1,486,339 | $1,713,758 | $666,221 |
| Change In Other Current Liabilities | $-12,167 | $-244,748 | $0 | - |
| Change In Other Current Assets | $-47,177 | $0 | - | - |
| Change In Payables And Accrued Expense | $2,394,527 | $1,854,714 | $1,738,532 | $754,147 |
| Change In Accrued Expense | $1,277,366 | $56,131 | $678,743 | $-50,000 |
| Change In Payable | $1,117,161 | $1,798,583 | $1,059,789 | $804,147 |
| Change In Account Payable | $1,117,161 | $1,798,583 | $1,059,789 | $804,147 |
| Change In Prepaid Assets | $-196,535 | $-123,627 | $-24,774 | $-87,926 |
| Other Non Cash Items | $3,362,551 | $3,178,545 | $11,327,295 | $206,891 |
| Stock Based Compensation | $35,555,059 | $0 | $0 | $1,291,909 |
| Asset Impairment Charge | $0 | $703,796 | $0 | - |
| Depreciation Amortization Depletion | $36,461 | $245,945 | $0 | - |
| Depreciation And Amortization | $36,461 | $245,945 | $0 | - |
| Depreciation | $36,461 | $245,945 | $0 | - |
| Gain Loss On Investment Securities | $689,543 | - | - | - |
| Net Income From Continuing Operations | $-62,146,210 | $-11,898,464 | $-14,921,065 | $-3,046,757 |
| Interest Paid Supplemental Data | - | - | $0 | $2,261 |
| Change In Other Working Capital | - | - | - | $-50,000 |
| Change In Receivables | - | - | - | $0 |
| Changes In Account Receivables | - | - | - | $0 |